Must pharmacists inform patients about the availability of a generic equivalent when dispensing a brand-name drug?

Pharmacists are required to inform patients about the availability of a generic equivalent when dispensing a brand-name drug, especially if a generic is available in stock. This practice is rooted in the principles of patient education and cost-effectiveness. The intent is to ensure that patients are fully informed about their medication options, which can lead to cost savings and potentially improved adherence to medication regimens.

By informing patients of the availability of generics, pharmacists empower them to make informed decisions about their medications. This is particularly important given that generics often provide the same therapeutic effect as their brand-name counterparts but at a lower cost. The obligation to inform applies whether or not the patient proactively inquires about alternatives. Patients have the right to know what options are available to them, thus enhancing their understanding and engagement in their own healthcare decisions.